Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext - PDF (Russian)


Copyright (c) 2019 Bakulev A.L., Samtsov A.V., Kubanov A.A., Khairutdinov V.R., Kokhan M.M., Artemyeva A.V., Derbin S.I., Chernyaeva E.V., Ivanov R.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies